Guardant Health, Inc. (GH) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1206 transactions totaling $2.3B, demonstrating a bearish sentiment with -$2.2B in net insider flow. The most recent transaction on Feb 21, 2026 involved a transaction of 264 shares valued at $0.
No significant insider buying has been recorded for GH in the recent period.
No significant insider selling has been recorded for GH in the recent period.
Based on recent SEC filings, insider sentiment for GH is bearish with an Insider Alignment Score of 1/100 and a net flow of -$2.2B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Guardant Health, Inc. (GH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading GH stock, having executed 1206 transactions in the past 90 days. The most active insider is Bluebird (cayman) Ltd Svf (Executive), who has made 2 transactions totaling $741.2M.
Get notified when executives and directors at GH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 21, 2026 | Mignone Roberto | Executive | Option Exercise | 264 | $N/A | $0 | |
| Feb 21, 2026 | Mignone Roberto | Executive | Option Exercise | 264 | $N/A | $0 | |
| Jan 21, 2026 | Mignone Roberto | Executive | Option Exercise | 264 | $N/A | $0 | |
| Jan 21, 2026 | Mignone Roberto | Executive | Option Exercise | 264 | $N/A | $0 | |
| Jan 17, 2026 | Manuel Hidalgo Medina | Executive | Option Exercise | 232 | $N/A | $0 | |
| Jan 17, 2026 | Manuel Hidalgo Medina | Executive | Option Exercise | 232 | $N/A | $0 | |
| Jan 1, 2026 | Eltoukhy Helmy | Executive | Option Exercise | 23,997 | $N/A | $0 | |
| Jan 1, 2026 | Eltoukhy Helmy | Executive | Payment | 10,788 | $102.14 | $1.1M | Large |
| Jan 1, 2026 | Eltoukhy Helmy | Executive | Option Exercise | 23,997 | $N/A | $0 | |
| Jan 1, 2026 | Talasaz Amirali | Executive | Option Exercise | 23,997 | $N/A | $0 | |
| Jan 1, 2026 | Talasaz Amirali | Executive | Payment | 10,788 | $102.14 | $1.1M | Large |
| Jan 1, 2026 | Talasaz Amirali | Executive | Option Exercise | 23,997 | $N/A | $0 | |
| Dec 31, 2025 | E. Krognes Steve | Executive | Option Exercise | 154 | $N/A | $0 | |
| Dec 31, 2025 | E. Krognes Steve | Executive | Option Exercise | 154 | $N/A | $0 | |
| Dec 31, 2025 | Eltoukhy Helmy | Executive | Option Exercise | 4,815 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 601 | $2.2B | 94.9% |
Payment(F) | 139 | $85.4M | 3.6% |
Purchase(P) | 30 | $25.2M | 1.1% |
Exercise(M) | 395 | $10.8M | 0.5% |
Other(J) | 16 | $0 | 0.0% |
Award(A) | 11 | $0 | 0.0% |
Gift(G) | 14 | $0 | 0.0% |
Insider selling pressure at Guardant Health, Inc. has increased, with 26 insiders executing 1206 transactions across all time. Total sales of $2.2B significantly outpace purchases of $25.2M, resulting in a net outflow of $2.2B. This selling activity appears largely discretionary, which may warrant closer attention from investors.